Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T16:02:08.746Z.
Calculation as of: 2026-10-06T16:02:08.746Z.
Quote observation: 2026-10-06T15:57:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c838c5f02617604a06e7cb0420d823d591f860cb8694f5d9431dbed4021aaa
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$2.73M
Price/FCF Ratio
22.27
TTM Avg
83.70
3Y Avg
7795.06
5Y Avg
7795.06
Market Cap
$2.92M
Price/FCF Ratio
N/A
TTM Avg
100.17
3Y Avg
2478.31
5Y Avg
2478.31
Market Cap
$3.10M
Price/FCF Ratio
N/A
TTM Avg
2.54
3Y Avg
2.54
5Y Avg
2.54
Market Cap
$3.12M
Price/FCF Ratio
N/A
TTM Avg
1508.93
3Y Avg
1508.93
5Y Avg
1508.93
Market Cap
$2.30M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DEFSEC Technologies Inc. (DFSC) | $2.75M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.73M | 22.27 | 83.70 | 7795.06 | 7795.06 |
| Top KingWin Ltd. Class A (DPU)vs › | $2.73M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $2.92M | N/A | 100.17 | 2478.31 | 2478.31 |
| PTL Limited (PTLE)vs › | $3.03M | N/A | N/A | N/A | N/A |
| Intelligent Group Limited (INTJ)vs › | $3.10M | N/A | 2.54 | 2.54 | 2.54 |
| Polar Power, Inc. (POLA)vs › | $3.12M | N/A | 1508.93 | 1508.93 | 1508.93 |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.30M | N/A | N/A | N/A | N/A |
| Iveda Solutions, Inc. (IVDA)vs › | $3.34M | N/A | N/A | N/A | N/A |
| Mint Incorporation Limited (MIMI)vs › | $2.16M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
